Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
ABN AMRO serves retail, private and commercial banking customers in the Netherlands and across the globe. Along with a comprehensive range of products and services, we offer in-depth financial expertise, extensive knowledge of numerous sectors and an international network supporting our customers’ domestic and international operations. We aim to respond to the ever-changing market and, in doing so, to our customers’ ever-changing needs. Customers want a bank that acts in the context of today’s realities and is straightforward with them at all times; a bank that learns from its experiences and whose top priority is to provide the best possible service.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2002 | AM Pharma | Series B | - |
11/2007 | BioVex | Series E | 35M |
10/2003 | BioVex | Series C | 28.4M |
2/2000 | clickNsettle.com | Venture Round | 8.8M |
3/2022 | In Ovo | Series B | 0 |
9/2002 | BEELINE Technologies | Venture Round | 11.2M |
5/2018 | Exasun | Venture Round | - |
6/2000 | Aucxis Corporation | Venture Round | 7.5M |
12/2004 | CircuLite | Series A | 7M |
5/2021 | Envision | Seed Round | 0 |
8/2000 | EcomXML | Venture Round | 0 |
12/2018 | Fairphone | Debt Financing | 14.7M |
7/2001 | UpShot Corporation | Series E | 17M |
3/2000 | BeXcom | Venture Round | 75M |
7/2005 | Xention | Series B | 13.3M |
10/2001 | Ardana Bioscience | Series A | 20M |
1/2004 | Accelerated Technologies | Series B | 32M |
12/1999 | Cortera | Venture Round | 0 |
2/2008 | Evenementenhal Hardenberg | Venture Round | - |
3/2005 | Alantos Pharmaceuticals | Series B | 0 |
5/2003 | Acorda Therapeutics | Series B | 55.3M |
11/2000 | Pluris | Series D | 0 |
8/2000 | BondDesk | Venture Round | - |
9/2022 | Exasun | Venture Round | 0 |
10/1999 | Drug Abuse Sciences | Venture Round | 22.4M |
3/2003 | Acadia Pharmaceuticals Inc. | Series F | 25M |
4/2000 | Cycore | Venture Round | 10M |
4/2004 | Cilian AG | Series B | 6.1M |
4/2000 | Telenisus | Series B | 50M |
7/2003 | Ardana Bioscience | Series B | 32.4M |
3/2006 | PanGenetics | Series B | 15.6M |
10/2004 | Bluebird Bio | Venture Round | 12M |
6/2004 | Bluebird Bio | Series A | 8.5M |
5/2007 | SPS Commerce | Venture Round | 7.5M |
2/2000 | Corechange Inc | Series B | 0 |
11/2002 | SPS Commerce | Venture Round | - |
3/2000 | IMX Exchange | Venture Round | 15.7M |
10/2004 | FlowMedica | Series C | 0 |
1/2003 | Impella Cardiosystems | Venture Round | 40M |
10/2001 | Mysticom | Venture Round | 28M |
6/2000 | LNG Holdings | Private Equity Round | 1.1B |
3/2001 | Drug Abuse Sciences | Series A | 46.5M |
10/2002 | Pieris AG | Series A | 0 |
1/2023 | Seepje | Venture Round | 4.6M |
5/2015 | Barge Master | Private Equity Round | - |
11/2019 | Picnic | Debt Financing | 55M |
12/2016 | Goodnight Midstream | Debt Financing | 0 |
1/2011 | Ensartech | Venture Round | - |
1/2000 | Integral Development Corp | Private Equity Round | 40M |
6/2000 | Xpede | Series B | 0 |
3/2016 | TradeBridge | Debt Financing | 69.8M |
8/2000 | Tradiant | Venture Round | 0 |
3/2022 | In Ovo | Series B | 0 |
5/2021 | Envision | Seed Round | 0 |
11/2019 | Picnic | Debt Financing | 0 |
12/2018 | Fairphone | Debt Financing | 0 |
5/2018 | Exasun | Venture Round | - |
12/2016 | Goodnight Midstream | Debt Financing | 0 |
3/2016 | TradeBridge | Debt Financing | 0 |
2/2016 | Digital Asset | Venture Round | 0 |
5/2015 | Barge Master | Private Equity Round | - |
1/2011 | Ensartech | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|